Get started
Award

Hhsn261200800001c

Funded outputs count: 3,242
Funder award ID: HHSN261200800001C
OpenAlex ID: G5888954722
Large-particle aerosol exposure to the Bangladesh or Malaysia strain of Nipah virus results in markedly divergent disease presentation in African Green Monkeys
2025 · Yu Cong, Jeremy Bearss, et al. · PLoS Pathogens · 3
PDF
The prostate is a common site of disease in patients with MEN2B and medullary thyroid carcinoma
2025 · Ira L Kraft, Srivandana Akshintala, et al. · Endocrine Related Cancer
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer
2025 · Margaret C Wheless, Shannon Stockton, et al. · The Oncologist · 1
PDF
Manganese mediates antiviral effects by driving an ATM -TBK1 phosphorylation signaling pathway
2025 · Hongyan Sui, Rosana Wiscovitch-Russo, et al. · Frontiers in Immunology · 3
PDF
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapy
2025 · Sonia Bakkour Coco, Mars Stone, et al. · Journal of Clinical Microbiology · 3
PDF
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials
2025 · Cloud P. Paweletz, Thomas D. Forbes, et al. · JCO Precision Oncology
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)
2025 · Liza C Villaruz, Benjamin Schluger, et al. · The Oncologist · 2
PDF
The histone methyltransferase MLL1 complex inhibits expression of fetal hemoglobin
2025 · Yufen Han, Bjorg Gudmundsdottir, et al. · Journal of Biological Chemistry · 1
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden
2025 · Minji K. Lee, Sandra A. Mitchell, et al. · Cancers · 6
PDF
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses
2025 · Alexandra A. Abu-Shmais, Gray Freeman, et al. · Nature Microbiology · 10
PDF
The TLR7 agonist vesatolimod does not measurably induce SIV expression in macaques receiving combination antiretroviral therapy initiated during chronic infection
2025 · Adrienne E. Swanstrom, Kelli Oswald, et al. · Antimicrobial Agents and Chemotherapy · 1
PDF
Identification of Cembrane Diterpenoids from Sinularia sp. That Reduce the Viability of Diffuse Pleural Mesothelioma Cell Lines
2025 · Maria Orfanoudaki, Anam F. Shaikh, et al. · Journal of Natural Products · 3
PDF
Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome
2025 · Ramya Ramaswami, Kathryn Lurain, et al. · Blood Advances · 13
PDF
Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 Vaccines
2025 · Cheng Cheng, Jeffrey C. Boyington, et al. · Vaccines · 1
PDF
The Discovery of Complex Heterocycles from Millipede Secretions
2025 · Paige Banks, Carla Menegatti, et al. · Journal of the American Chemical Society · 4
PDF
Kaposi Sarcoma‐Associated Herpesvirus Sequencing in People Living With HIV in the Southern United States Reveals Subtype Diversity and Multiple Infections
2025 · Vickie A. Marshall, Sheena M. Knights, et al. · Journal of Medical Virology · 5
PDF
IL-27 effects on HIVGag-specific CD4 and CD8 T cell function
2025 · Maryam Abdussamad, Grace Katz, et al. · Frontiers in Virology · 1
PDF
Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas
2025 · Geraldine O’Sullivan Coyne, Shivaani Kummar, et al. · Cancer Chemotherapy and Pharmacology · 5
PDF
Nonclinical Safety Evaluation of 2-Deoxy-D-Glucose Following Twice-Daily Oral Administration for 28 Days in Beagle Dogs
2025 · Rahul M. Nandre, Pramod S. Joshi, et al. · International Journal of Toxicology · 2
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
2025 · Yvonne A. Evrard, Sergio Y. Alcoser, et al. · Frontiers in Oncology · 1
PDF
HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia
2025 · James Soka Moses, Alice K. Pau, et al. · Communications Medicine · 3
PDF
Tumor-associated long non-coding RNAs show variable expression across diffuse gliomas and effect on cell growth upon silencing in glioblastoma
2025 · Joonas Uusi-Mäkelä, Maria Kauppinen, et al. · Scientific Reports
PDF
Whole‐genome sequencing of 1,083 HPV45 cases and controls identifies genetic variants associated with glandular cervical lesions
2025 · Aimee J. Koestler, Chase W. Nelson, et al. · International Journal of Cancer · 5
PDF
Biomarkers in advanced renal cell carcinoma: current practice and future directions
2025 · Vivian Wong, Taylor Goodstein, et al. · Current Opinion in Oncology · 11
PDF
Transfer RNA acetylation regulates in vivo mammalian stress signaling
2025 · Supuni Thalalla Gamage, Roxane Khoogar, et al. · Science Advances · 18
Year
Topic